Jp. Cazenave et al., EPOETIN ALFA FACILITATES PRESURGICAL AUTOLOGOUS BLOOD DONATION IN NONANEMIC PATIENTS SCHEDULED FOR ORTHOPEDIC OR CARDIOVASCULAR-SURGERY, European journal of anaesthesiology, 14(4), 1997, pp. 432-442
Patients expected to need at least three units of blood for their elec
tive cardiovascular or orthopaedic surgery, were allocated randomly to
receive intravenous (i.v.) Epoetin alfa 600 IU kg(-1) (n=27), 300 IU
kg(-1) (n= 30) or placebo (n=23), on days 1, 4 and 7. Provided haemogl
obin greater than or equal to 11g dL(-1), one unit of blood was collec
ted on days 1, 4, 7, 11 and 14. Iron supplementation was given through
out the study. Surgery was scheduled between days 18 and 21. Significa
ntly more patients treated with Epoetin alfa (100% for 600 IU kg(-1);
97% for 300 IU kg(-1)) were able to donate 24 units of blood compared
with placebo (78%) (P = 0.011 and P=0.032). No significant differences
were seen in total patient exposure to homologous blood (7.4%, 3.3% a
nd 17.4%, respectively). Mean red cell volume donated (P=0.005 for 600
IU kg(-1); P=0.158 for 300 IU kg(-1) both vs. placebo) and production
(P<0.001 and P=0.012, respectively) were dose related. Twenty-four pa
tients became iran deficient. No differences in the incidence of adver
se events were seen between the groups.